High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion
Author(s) -
Chunjie Gu,
Feng Xie,
Bing Zhang,
HuiLi Yang,
Jiao Cheng,
Yinyan He,
XiaoYong Zhu,
DaJin Li,
MingQing Li
Publication year - 2018
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000494237
Subject(s) - cancer research , estrogen receptor , glut4 , biology , viability assay , gene silencing , epithelial–mesenchymal transition , estrogen , glucose transporter , chemistry , endocrinology , medicine , metastasis , cell , breast cancer , cancer , insulin , biochemistry , gene , genetics
Uterus endometrial cancer (UEC) is the common malignancy among gynecologic cancers, and most of them are type I estrogen-dependent UEC. Diabetes is well-known risk factor for the development of UEC. However, the underlying link between high glucose (HG) and the estrogen receptor in UEC remains unclear. Epithelial-mesenchymal transition (EMT) has also been shown to occur during the initiation of metastasis in cancer progression. The aim of this study was to determine the relationships and roles of HG, estrogen receptor and EMT in the growth and migration of UEC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom